This is Money
UK · 1 hrs ago
GSK shares drift despite drug approvals boost
Drugs giant GSK saw its shares drift lower despite announcing progress on two key products yesterday.
Do you trust This is Money?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!